Literature DB >> 23807458

Fluorescence study of the membrane effects of aggregated lysozyme.

Olga K Kutsenko1, Valeriya M Trusova, Galyna P Gorbenko, Anna S Lipovaya, Ekaterina I Slobozhanina, Lyudmila M Lukyanenko, Todor Deligeorgiev, Aleksey Vasilev.   

Abstract

The last decade has seen unprecedented upsurge of interest in the structural and toxic properties of particular type of protein aggregates, amyloid fibrils, associated with a number of pathological states. In the present study fluorescence spectroscopy technique has been employed to gain further insight into the membrane-related mechanisms of amyloid toxicity. To this end, erythrocyte model system composed of liposomes and hemoglobin was subjected to the action of oligomeric and fibrillar lysozyme. Acrylamide quenching of lysozyme fluorescence showed that solvent accessibility of Trp62 and Trp108 increases upon the protein fibrillization. Resonance energy transfer measurements suggested the possibility of direct complexation between hemoglobin and aggregated lysozyme. Using the novel squaraine dye SQ-1 it was demonstrated that aggregated lysozyme is capable of inhibiting lipid peroxidation processes. Fluorescent probes pyrene, Prodan and diphenylhexatriene were employed to characterize the membrane-modifying properties of hemoglobin and lysozyme. Both oligomeric and fibrillar forms of lysozyme were found to exert condensing influence on lipid bilayer structure, with the membrane effects of fibrils being less amenable to modulation by hemoglobin.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23807458     DOI: 10.1007/s10895-013-1254-2

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  43 in total

1.  Denaturation and aggregation of hen egg lysozyme in aqueous ethanol solution studied by dynamic light scattering.

Authors:  S Tanaka; Y Oda; M Ataka; K Onuma; S Fujiwara; Y Yonezawa
Journal:  Biopolymers       Date:  2001-10-15       Impact factor: 2.505

2.  Interaction of different forms of haemoglobin with artificial lipid membranes.

Authors:  L Bossi; S Alemà; P Calissano; E Marra
Journal:  Biochim Biophys Acta       Date:  1975-02-14

3.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

Review 4.  Amyloidogenic protein-membrane interactions: mechanistic insight from model systems.

Authors:  Sara M Butterfield; Hilal A Lashuel
Journal:  Angew Chem Int Ed Engl       Date:  2010-08-02       Impact factor: 15.336

5.  Membrane fluidity of platelets and erythrocytes in patients with Alzheimer's disease and the effect of small amounts of aluminium on platelet and erythrocyte membranes.

Authors:  S J van Rensburg; M E Carstens; F C Potocnik; A K Aucamp; J J Taljaard; K R Koch
Journal:  Neurochem Res       Date:  1992-08       Impact factor: 3.996

6.  Three dimensional fourier synthesis of horse deoxyhaemoglobin at 2.8 Angstrom units resolution.

Authors:  W Bolton; M F Perutz
Journal:  Nature       Date:  1970-11-07       Impact factor: 49.962

7.  Role of heme compounds in the erythrocyte membrane damage induced by lipid hydroperoxide.

Authors:  M Beppu; M Nagoya; K Kikugawa
Journal:  Chem Pharm Bull (Tokyo)       Date:  1986-12       Impact factor: 1.645

8.  Amyloid-beta peptide affects the oxygen dependence of erythrocyte metabolism: a role for caspase 3.

Authors:  M Elisabetta Clementi; Bruno Giardina; Deborah Colucci; Antonio Galtieri; Francesco Misiti
Journal:  Int J Biochem Cell Biol       Date:  2006-11-30       Impact factor: 5.085

9.  Prodan as a membrane surface fluorescence probe: partitioning between water and phospholipid phases.

Authors:  E K Krasnowska; E Gratton; T Parasassi
Journal:  Biophys J       Date:  1998-04       Impact factor: 4.033

10.  Amyloid peptide inhibits ATP release from human erythrocytes.

Authors:  Francesco Misiti; Federica Orsini; M Elisabetta Clementi; Daniele Masala; Ester Tellone; Antonio Galtieri; Bruno Giardina
Journal:  Biochem Cell Biol       Date:  2008-12       Impact factor: 3.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.